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Accepted 14 January 2017Introduction. Brown adipose tissue (BAT) is a thermogenic organ with substantial
metabolic capacity and has important roles in the maintenance of body weight and
metabolism. Regulation of BAT is primarily mediated through the β-adrenoceptor (β-AR)
pathway. The in vivo endocrine regulation of this pathway in humans is unknown. The
objective of our study was to assess the in vivo BAT temperature responses to acute
glucocorticoid administration.
Methods. We studied 8 healthy male volunteers, not pre-selected for BAT presence or
activity and without prior BAT cold-activation, on two occasions, following an infusion with
hydrocortisone (0.2 mg.kg−1.min−1 for 14 h) and saline, respectively. Infusions were given in a
randomized double-blind order. They underwent assessment of supraclavicular BAT
temperature using infrared thermography following a mixed meal, and during β-AR
stimulation with isoprenaline (25 ng.kg fat-free mass−1.min−1 for 60 min) in the fasting state.
Results. During hydrocortisone infusion, BAT temperature increased both under fasting
basal conditions and during β-AR stimulation. We observed a BAT temperature threshold,
which was not exceeded despite maximal β-AR activation. We conclude that BAT
thermogenesis is present in humans under near-normal conditions. Glucocorticoids
modulate BAT function, representing important physiological endocrine regulation of
body temperature at times of acute stress.
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There is increasing evidence that brown adipose tissue (BAT) has
important physiological roles beyond thermoregulation in new-
born infants and rodents [1]. Adult humans have significant
amounts of BAT [2] and, as a highly metabolic tissue with the
capacity to oxidize both glucose and lipid, attention has turned to
its involvement in the pathogenesis of obesity and themetabolic
syndrome [3]. BAT is characterized by the presence of uncoupling
protein (UCP) 1 which uncouples adenosine triphosphate (ATP)
production by themitochrondrial respiratory chain, allowing the
dissipation of excess chemical energy as heat [4]. The principal
factors regulating BAT function in healthy adults have yet to be
fully established due, in part, to the technical limitations of
assessing BAT function in vivo. The majority of studies in
humans have used 18F-fluorodeoxyglucose-positron emission
tomography/computed tomography (18FDG-PET/CT) as the gold
standard to assess BAT activity, but this is constrained by
exposure to ionizing radiation, the scanning protocols involved
[5] and its unsuitability for live tracking of BAT activation
especially after feeding. Systemic β-adrenoceptor (β-AR) activa-
tion promotes BAT activity in humans [6], but the role of other
endocrine factors remains largerly unknown. The pre-partum
elevation of cortisol is pivotal in the initiation of nonshivering
BAT thermogenesis at birth [7], and glucocorticoids have recently
been proposed as regulators of BAT activity in healthy adult
females [8] and in individuals pre-selected for the presence of
active BAT [9]. BAT has also been considered to contribute to
dietary-induced thermogenesis [10,11], although this concept
remains controversial [12].We, therefore, studiedwhether BAT is
activated by feeding, or by an acute increase in cortisol under
basal and β-AR stimulated conditions.2. Materials and Methods
2.1. Subjects
Eight healthy male volunteers participated in this randomized,
double-blind, placebo controlled study, conducted between
January and March 2015. Individuals were recruited using
print and electronic advertising and none was selected or
screened on the basis of presence of any active BAT. All subjects
underwent a medical evaluation during a screening visit to
ensure they were healthy. No subject had any significant past
medical history, smoked tobacco or took any regular medica-
tions that could affect the study's outcome measures.
2.2. Study Approval
The study was approved by the Edgbaston NRES Committee,
UK (REC reference 14/WM/1085). All participants provided
written informed consent.
2.3. Study Design
2.3.1. Clinical Research Facility
All parts of this studywere conducted in a temperature controlled
room at the National Institute for Health Research (NIHR)/Wellcome Trust Clinical Research Facility (CRF) of the University
of Birmingham at the Queen Elizabeth Hospital Birmingham, UK.
Room temperature was held constant at 23–26 °C and was
monitored using an ambient temperature probe.
2.3.2. Anthropometric Measurements
Measurements were taken during the screening visit. Waist
circumferencewasmeasuredmidway between the lowermargin
of the last palpable rib and the top of the iliac crest, and hip
circumference at the level of the greater trochanters. Total and
regional fat masses were measured by dual-energy x-ray
absorptiometry (DXA). Visceral fat mass was estimated by DXA
using a proprietary algorithm provided by themanufacturer [13].
Core temperature was measured with a tympanic thermometer.
2.3.3. Study Visits
Study visits were identical, except for the nature of overnight
infusion, andwere at least 2 weeks apart (Fig. 1A). Subjectswere
admitted to theCRF in the afternoon, and a cannula for infusion
purposes was inserted into a right antecubital fossa vein. At
1800 h, they were served a standardized calorie-controlled
meal (vegetable lasagne; total energy 2634 kJ; typical nutritional
values per 100 g of product: 1.9 g fat, 12.2 g carbohydrates, 3.3 g
protein, 1.5 g fiber), and then fasted until study completion the
next day. BAT thermogenesis assessment was performed
immediately before and after the meal, which was ingested
within 20 min and was acompanied by tap water at room
temperature. At 1900 h, a constant infusion of either hydrocor-
tisone (HC, 0.2 mg.kg−1.h−1) or normal saline (control study
visit) was started and given until study completion the
following day. Infusions were administered in a double-blind,
randomized fashion. At 2200 h, lights were switched off for
night rest. In the morning, cannulations for blood sampling
purposes were performed and, at 0900 h, the isoprenaline
infusion protocol commenced. After baseline measurements
for 45 min, a one-step infusion of isoprenaline (ISO, 25 ng.kg
fat-free mass−1.min−1) was given for 60 min. BAT thermogenic
activity wasmeasured at baseline and throughout the infusion.
2.4. BAT Thermogenesis Assessment
An infrared thermography (IT) camera (FLIR E60 2.3 Megapixel
Infrared Camera; FLIR Systems, Danderyd, Sweden) was used to
acquire images of the anterior neck and upper chest region,
which were sequentially analyzed and processed by an auto-
mated analysis program, as described previously [14]. Areas of
interest for temperature analysis were the supraclavicular region
(TSCR) representingBAT, andanon-adipose tissue referencepoint
(TREF) on the chest, close to the xiphoid. In addition, during the
periods of IT, two skin contact temperature sensors (iButton
DS1922L, Maxim Integrated, Winnersh, UK) recording skin
temperature everyminutewere tapedwithin the supraclavicular
fossa (main BAT site) and lateral to the umbilicus (white adipose
tissue). For skin contact temperature measurements, data were
collected everyminute, and analysis was performed using 5-min
averages. For meal meaurements, the mean of both study days
was calculated. Fasting and pre-ISO baseline were defined as the
average of time points −15 to 0 min. Postprandial and peak post-
ISO infusion periods were defined as time points 0 to 15 min and
40 to 50 min, respectively. For the duration of the study,
Fig. 1 – Study design and temperature responses to a meal. Each participant underwent the study twice, whereby BAT
thermogenic activity was studied with infrared thermography before and after a standardized meal, followed by either a 14 h
overnight constant hydrocortisone or normal saline (control) infusion. Infusions were given in a randomized, double-blind
order and continued during and after β-adrenoceptor stimulation with isoprenaline (A). Mean changes in supraclavicular
region (TSCR, gray circles) and non-adipose tissue reference (TREF, open squares) temperatures (dotted line indicates time of
meal) (B), individual responses (fasting, open squares; postprandial, black squares) (C), and changes in core temperature
(fasting, open circles; postprandial, black squares) (D) following the meal. *p < 0.05 compared to fasting baseline, n = 8.
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exposed for the duration of all measurements.
2.5. Analytical Methods
Blood sampleswere drawn into heparinized syringes, and plasma
was prepared rapidly at 4 °C and immediately frozen at −80 °C
before analysis. Plasma glucose and NEFA concentrations were
measured enzymatically using commercially available kits on an
ILAB600 or ILAB650 clinical analyzer (Instrumentation Laboratory
UK, Warrington, UK). Insulin and C-peptide were measured by
ELISA (Invitron,Monmouth,UK) at a reference laboratory (Diabetes
Research Unit Cymru, Swansea University, UK). Cortisol was
measured by a colorimetric assay (R&D Systems, Abingdon, UK).
2.6. Calculations and Statistics
Indexes of β-cell function and insulin resistance were calculated
according to the homeostaticmodel assessment (HOMA)method,
whereby the mean of three consecutive plasma glucose and
insulin postabsorptivemeasurements was used. Energy expendi-
ture was calculated based on heart rate, age and weight as
previously described [15]. Area under the curve (AUC) was
calculated using the trapezoid rule and is presented as a time-
averaged value (tAUC; AUC divided by the relevant time period).
Comparisons between groups were analyzed using t test or non-parametric tests for data that were not normally distributed. A
p < 0.05 was considered statistically significant. Based on previ-
ous studies using a similar integrative physiology design [16], the
sample sizewasdesigned tohave85%power todetect adifference
of 0.75 standard deviations at the 5% significance level for
metabolic parameters. Data were analyzed using IBM Statistics
forWindows v21 andGraphPad Prism forWindows v6.05. All data
are presented as mean ± SEM, unless otherwise stated.3. Results
3.1. Meal IngestionLeads to IncreasedBATThermogenicActivity
Baseline anthropometric and metabolic characteristics of
participants are shown in Table 1 and environmental temper-
ature data for each individual study day are shown in
Supplemental Table 1. There was no difference in outside or
room temperature between study days. Following the mixed
meal, postprandial TSCR increased, whereas TREF remained
stable (Fig. 1B). All participants responded with an increase in
BAT thermogenic activity (Fig. 1C), while core temperature did
not change (Fig. 1D). Skin contact measurements showed a
similar postprandial temperature increase of 0.39 ± 0.10 °Cover
supraclavicular BAT (p < 0.05 compared to fasting), whereas
skin temperature overwhite adipose tissue remained the same.
Table 1 – Baseline anthropometric and metabolic
characteristics of participants, n = 8.
Characteristic
Age (years) 20 (18–34)
Weight (kg) 75.0 (61.5–81.7)
BMI (kg/m2) 23.0 (20.6–24.2)
WHR 0.84 (0.78–0.9)
Trunk fat (kg) 7.7 (5.1–9.2)
Leg fat (kg) 5.5 (4.3–7.5)
Visceral fat (kg) 0.2 (0.1–0.4)
Systolic BP (mmHg) 124 (105–145)
Diastolic BP (mmHg) 72 (59–79)
Heart rate (bpm) 58 (53–62)
Fasting glucose (mg/dL) 113 (89–122)
Fasting insulin (pmol/L) 30.6 (14.4–68.5)
Fasting NEFA (μmol/L) 707 (450–873)
TSH (mIU/L) 1.30 (0.93–4.83)
FT4 (pmol/L) 17.7 (15.0–18.8)
Median and range shown. BMI, body mass index; WHR, waist-to-
hip ratio; BP, blood pressure; TSH, thyroid stimulating hormone;
FT4, free thyroxine.
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Resistance and Increases Basal BAT Thermogenic Activity
Overnight HC infusion resulted in significantly increased
plasma cortisol concentrations (Fig. 2A). From a metabolic
perspective, basal plasma non-esterified fatty acids (NEFAs)
were high due to fasting (Fig. 2B). HC increased basal NEFAFig. 2 – Metabolic and cardiovascular responses following saline
during an isoprenaline infusion (ISO, dotted lines indicate infusi
circles; hydrocortisone, black squares) (A), non-esterified fatty ac
squares) (B), glucose (saline, open circles; hydrocortisone, black s
circles; hydrocortisone, black circles) (D) and core temperature at
squares) (E). Systolic (sys) and diastolic (dia) blood pressure (BP)
hydrocortisone, black bars) (F). *p < 0.05 vs. control, n = 8.and glucose (Fig. 2C), as well as insulin (basal insulin 30.4 ±
6.0 pmol/L vs. 55.2 ± 7.4 pmol/L, p = 0.025 control compared
to hypercortisolemia) and C-peptide concentrations (basal C-
peptide 0.25 ± 0.03 pmol/mL vs. 0.38 ± 0.04 pmol/mL, p =
0.001 control compared to hypercortisolemia). In line with
this, HOMA indices of peripheral insulin resistance increased
(HOMA IR index control 0.62 ± 0.11 vs. hypercortisolemia
1.11 ± 0.16, p = 0.016) (Table 2).
Acute hypercortisolemia increased TSCR in the basal state
(Fig. 2D). This was accompanied by an increase in basal core
temperature (Fig. 2E), but we did not observe any effect on
blood pressure or heart rate (Fig. 2F).
3.3. Acute β-AR Stimulation Increases BAT Thermogenic
Activity During Control and Hypercortisolemia Conditions
From a metabolic perspective, ISO infusion significantly
increased systemic NEFA concentrations, both under control
and hypercortisolemia conditions (Fig. 2B). Despite the
augmentation of basal systemic lipolysis by HC, the β-AR
dependent rise in plasma NEFA was of similar magnitude
compared to control conditions (Δ AUC 953 ± 155 vs 979 ±
175 μmol/L; p = 0.926 compared to control). Following the
initial peak, there was a sharp decline in NEFA concentrations
despite continuing ISO infusion. Control plasma glucose concen-
trations were unaffected by ISO, while the observed increase in
concentrations during HC infusion is due to glucocorticoid-
induced peripheral tissue insulin resistance (Fig. 2C). This is
supported by the concomitant changes in insulin, C-peptide andinfusion (S) or hydrocortisone infusion (HC) at baseline and
on period). Plasma cortisol concentrations (saline, open
ids (NEFA) (saline, open circles; hydrocortisone, black
quares) (C), supraclavicular temperature (TSCR) (saline, open
baseline (saline, open squares; hydrocortisone, black
and heart rate (HR) at baseline (saline, open bars;
Table 2 – Comparison of insulin and C-peptide AUC, and homeostatic model assessment (HOMA) indexes during basal and
isoprenaline-stimulated conditions, n = 8.
Control Cortisol P value control
vs cortisol
P value basal vs
isoprenaline
Basal ISO Basal ISO Basal ISO Control Cortisol
Insulin (pmol/L) 30.4 ± 6.0 100.4 ± 15.7 55.2 ± 7.4 206.7 ± 30.5 0.025 0.012 0.012 0.012
C-peptide (pmol/mL) 0.25 ± 0.03 0.47 ± 0.05 0.38 ± 0.04 0.90 ± 0.09 0.001 0.001 <0.0001 <0.0001
Control Cortisol P value
Δ insulin basal to ISO (pmol/L) 70.0 ± 10.1 151.5 ± 28.9 0.012
Δ C-peptide basal to ISO (pmol/mL) 0.22 ± 0.03 0.52 ± 0.07 0.012
HOMA %B 42.2 ± 5.9 40.5 ± 4.5 0.731
HOMA %S 192.2 ± 29.5 105.9 ± 19.2 0.004
HOMA IR 0.62 ± 0.11 1.11 ± 0.16 0.016
Mean and SEM shown.
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a significant increase in insulin and C-peptide concentrations
during ISO infusion (Table 1). Expectedly, non-selective β-AR
stimulation with ISO increased heart rate and systolic blood
pressure, responses not significantly affected by HC (Fig. 2F and
Supplemental Fig. 1). Basal and ISO-induced BAT thermogenic
activity measures did not show any significant correlation with
BMI or measures of adipose tissue distribution (data not shown).Fig. 3 – BAT thermogenic responses. Supraclavicular temperatur
following saline (S) infusion (TSCR, gray circles; TREF open square
open squares) (B) during and after isoprenaline stimulation (ISO
temperatures during ISO (S, open circles; HC, black circles) (C). Ch
meal (TSCR, gray bars; TREF open bars) (D). *p < 0.001 vs. basal, †p
n = 8.Adrenergic stimulation resulted in a highly localized in-
crease in temperature within the supraclavicular region,
representative of BAT thermogenic activity, both under control
and hypercortisolemic conditions (Fig. 3). All study participants
responded to ISO with an increase in BAT temperature
(Supplemental Fig. 2). Under control conditions, ISO increased
TSCR by 0.7 °C, plateaued and then returned to baseline after the
infusion, implying cessation of β-adrenergic-mediated BATe (TSCR) and non-adipose tissue reference point (TREF)
s) (A) or hydrocortisone (HC) infusion (TSCR, gray circles; TREF
, dotted lines indicate infusion period). Individual peak BAT
ange in temperature during ISO or following a standardized
< 0.05 vs. saline, #p < 0.001 vs. saline, ##p < 0.001 vs. TREF,
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during hypercortisolemia (Fig. 3B), whereby peak TSCR was
slightly higher (Fig. 3C). The ISO-induced TSCR increase was
greater than the physiological stimulus of diet-induced
thermogenesis (Fig. 3D). Skin temperature showed similar
results (Supplemental Fig. 3). Energy expenditure increased
significantly during ISO (Supplemental Fig. 4). During
hypercortisolemia, ISO-induced energy expenditure was close-
ly correlatedwith basal TSCR during control conditions (Pearson
r = 0.742, p = 0.035) and peak TSCR during HC (r = 0.870, p =
0.005). In response to ISO, peak core temperature was similar
between control and hypercortisolemia conditions (Supple-
mental Fig. 5).4. Discussion
Human supraclavicular BAT is characterized by the presence
of thermogenically functional UCP1, with a respiratory
capacity that substantially exceeds that of white fat [17].
Understanding the endocrine factors regulating BAT function
is an important prerequisite before being able to utilize the
metabolic capabilities of this tissue. In this study we sought to
study BAT in vivo following exposure to a combination of
physiological stimuli in order to determine the relative
importance of diet and edocrine mediated effects.
BAT glucose uptake has been reported to be increased
following a single carbohydrate-rich meal [18], although
overfeeding for 24 h did not have any effect [19]. This has
led to some controversy regarding the contribution of BAT to
dietary-induced thermogenesis in humans. We sought to
investigate this using a single standardized mixed meal,
serving as a physiological stimulus.While we did notmeasure
whole body energy expenditure, we observed selective
temperature changes over the supraclavidular region only,
immediately after the meal, suggesting direct BAT activation
and not a thermic effect of food. Interestingly, from a
mechanistic perspective, postprandial BAT activation would
be characterized by both systemic cortisol secretion [20] and
sympathetic β-AR stimulation [21], suggesting an acute
maximal response following feeding.
Cortisol promotes important physiological maturation
effects around the time of birth, including raised UCP1
abundance in adipose tissue [7,22]. However, in adult rodents,
glucocorticoids inhibit BAT [23] by interfering with adrenergic
signaling [24,25]. Human data are scarce with one study
reporting dexamethasone-induced inhibition of UCP1 expres-
sion and metabolic rate in human brown adipocytes in vitro
[26], and another reporting BAT activation following admin-
istration of the synthetic glucocorticoid prednisolone in vivo
[9]. In our study, we chose hydrocortisone to model a
physiological acute surge of cortisol, as seen during the
perinatal period and at times of acute stress. We observed
an increase of basal TSCR during hypercortisolemia,
supporting a physiological role for cortisol in BAT activation,
as we did not observe any additive effects on blood pressure
or heart rate. The duration of the infusion was chosen to
allow for glucocorticoid-mediated genomic effects to take
place [27]. While the achieved plasma cortisol concentrationswere in excess of those typical for acute stress [28], it is
important to note that tissue-responsiveness can be deter-
mined by tissue-specific glucocorticoid metabolism rather
than absolute plasma concentrations [29]. Taken together our
data indicate the positive relationship between cortisol and
BAT temperature as previously indicated from a small study
on healthy adult females [8].
β-AR stimulation induces BAT thermogenesis in humans
[6,30], although findings are inconsistent depending on the β-
AR employed [31,32]. We found a localized increase in
supraclavicular temperature during ISO infusion both under
control and hypercortisolemia conditions. This temperature
change was temporally limited for the duration of the
infusion, suggesting underlying BAT activation. TSCR re-
sponses for all subjects increased within the first 5 min
which is in accordance with acute cold exposure on BAT
[14]. The observed TSCR plateau is suggestive of a limit to BAT
thermogenesis in vivo. The concomitant sharp decline in
NEFA concentrations during the later stages of the infusion is
consistent with β-AR desensitization due tomaximal receptor
stimulation [16]. The finding of a slightly higher peak TSCR
during hypercortisolemia suggests a minor synergistic effect
between cortisol and β-AR stimulation. Interestingly, the two
pathways are intrinsically connected as catecholamine syn-
thesis is under glucocorticoid control [33].
Previous studies have shown that active BAT decreases
with age and obesity, and its activation varies between sexes
[14,34]. We studied BAT activity in healthy males using IT to
assess temperature changes in the supraclavicular region and
a non-adipose tissue reference point. Supraclavicular skin
temperature increases upon BAT activation [35,36] and IT has
been shown to measure changes in skin temperature overly-
ing the main BAT depot in humans [14]. It has been confirmed
as a reliable alternative for in vivo BAT activity assessment,
correlating with 18FDG-PET/CT [9,37], with the additional
benefit of enabling real-time tracking of temperature changes.
IT-derived BAT temperature measurements might be influ-
enced by subcutaneous adipose tissue thickness [38], howev-
er, in our study participants were lean and we monitored
dynamic temperature changes over time, as opposed to a
single, static measurement. Adrenoceptor-induced vasodila-
tion, both as a result of HC and ISO infusions, could increase
skin blood flow and interfere with IT measurements. Howev-
er, compared to TSCR, there were clear temporal differences in
the change in TREF which showed a later initial increase and a
sustained increase post-infusion. Overall, we demonstrate a
BAT-specific thermogenic and vasodilation response to both
HC and ISO, clearly differentiated from non-BAT reference
areas, confirming that the temperature responses we mea-
sured are confined to BAT.
Our findings support previous studies showing β-AR
stimulation as a means of activating BAT in humans [6,30],
confirming IT as a sensitive, non-invasive method for the in
vivo assessment of BAT function in humans under near-
normal conditions [9,14,37]. This is particularly important
when comparing our results with those studies using glucose
tracer uptake as an index of BAT activity. Similar ISO doses
did not show any significant BAT glucose tracer uptake, likely
due to competition between the tracer and fatty acids from
ISO-induced lipolysis combined with increased insulin
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for heat generation [1], it is possible that 18FDG-PET/CT
underestimates the amount of active BAT in humans. This
limitation has led to the development of alternative BAT
assessment methods, in addition to IT, either using different
PET/CT tracers [39], or based on magnetic resonance imaging
techniques [40]. We demonstrate that temperature changes in
the supraclavicular area upon β-AR stimulation are indicative
of localized BAT activity in a cohort of unselected young
individuals, maintained at room temperature. This supports
the prospect of harnessing BAT activity and the associated
increase in energy expenditure as a potential treatment
for metabolic diseases. We provide further evidence that in
humans, in contrast to rodents, acute hypercortisolemia
does not inhibit BAT function, but results in BAT activation
[9]. Despite this, there is a threshold of activity that cannot
be overcome even during maximal short-term β-AR
stimulation.
Our study has some limitations by design, including the
small size of our sample, although it is standard for a healthy
volunteer study of this type. The acute infusion of hydrocor-
tisone limits the conclusions we can draw in relation to states
of chronic glucocorticoid excess that are associated with
profound metabolic changes, i.e. Cushing's Syndrome. In
addition, the concomitant induction of relative insulin
resistance during hydrocortisone infusion might have ob-
scured glucocorticoid-specific effects on BAT function, espe-
cially since there is a complex relationship between insulin-
mediated glucose uptake and BAT perfusion and activity in
vivo [41]. The strenghts of our study are the randomized
double-blind design of the infusion protocol and that all
measurements were carried out within a short period of time,
reducing the confounding effect of variations seasonal
temperature, and thus endogenous BAT activity. In addition,
by using IT for the assessment of BAT thermogenic activity,
we were able to perform live tracking of BAT function in
response to experimental stimuli.
In conclusion, glucocorticoids modulate BAT thermogene-
sis andmay represent an important physiological mechanism
for maintaining human body temperature at times of acute
stress. Our study suggests that transient stress could act to
promote BAT function. This suggests that depending on the
type andmagnitude of stress BAT could be utilized to improve
body weight regulation and metabolic homeostasis.Authors’ contributions
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